OXS-1750

N/A

Report date: 2025/01/26 16:32:53

Base Information

Drug NameOXS-1750
Drug Alias Nameantibody-drug conjugate containing OXS-4235OXS-1750
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionSequestosome 1 inhibitors
TargetsSequestosome 1
Therapy Area/IndicationsOsteoporosisMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOxis Biotech
China Registration ClassN/A

Develop Information

Active CompaniesMultiCell ImmunoTherapeutics IncOxis Biotech
Inactive CompaniesN/A
Active IndicationsOsteoporosisMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A